Patents by Inventor Sofi Nöjd

Sofi Nöjd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID ORAL PHARMACEUTICAL DOSAGE FORM
    Publication number: 20220362150
    Abstract: A liquid oral pharmaceutical dosage form, comprising pharmacologically effective amounts of at least one histamine H2-receptor antagonist in a hydrophobic/lipophilic liquid substantially free from water comprising at least one viscosity enhancing agent, and pharmacologically effective amounts of one or more antacid(s) in a liquid comprising at least one viscosity enhancing agent and at least one flavor, wherein the two liquids are physically separated from each other and wherein the two liquids have matching rheological profiles and a package comprising multiple liquid oral dosage forms as well as a method of treating a gastric disease or disorder by use of the liquid oral pharmaceutical dosage form.
    Type: Application
    Filed: July 26, 2022
    Publication date: November 17, 2022
    Inventors: Salih Muhsin Muhammed, Katarina Lindell, Jill Nilgard, Sofi Nöjd
  • Liquid oral pharmaceutical dosage form
    Patent number: 11433024
    Abstract: A liquid oral pharmaceutical dosage form, comprising pharmacologically effective amounts of at least one histamine H2-receptor antagonist in a hydrophobic/lipophilic liquid substantially free from water comprising at least one viscosity enhancing agent, and pharmacologically effective amounts of one or more antacid(s) in a liquid comprising at least one viscosity enhancing agent and at least one flavor, wherein the two liquids are physically separated from each other and wherein the two liquids have matching rheological profiles and a package comprising multiple liquid oral dosage forms as well as a method of treating a gastric disease or disorder by use of the liquid oral pharmaceutical dosage form.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: September 6, 2022
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Salih Muhsin Muhammed, Katarina Lindell, Jill Nilgard, Sofi Nöjd
  • LIQUID ORAL PHARMACEUTICAL DOSAGE FORM
    Publication number: 20210106524
    Abstract: A liquid oral pharmaceutical dosage form, comprising pharmacologically effective amounts of at least one histamine H2-receptor antagonist in a hydrophobic/lipophilic liquid substantially free from water comprising at least one viscosity enhancing agent, and pharmacologically effective amounts of one or more antacid(s) in a liquid comprising at least one viscosity enhancing agent and at least one flavor, wherein the two liquids are physically separated from each other and wherein the two liquids have matching rheological profiles and a package comprising multiple liquid oral dosage forms as well as a method of treating a gastric disease or disorder by use of the liquid oral pharmaceutical dosage form.
    Type: Application
    Filed: April 24, 2019
    Publication date: April 15, 2021
    Inventors: Salih Muhsin Muhammed, Katarina Lindell, Jill Nilgard, Sofi Nöjd